Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
How to Overcome Cardiovascular Challenges in Covid-19 Patients: A Guide for Common Practice Publisher Pubmed



Eslami P1 ; Tabary M2 ; Dooghaiemoghadam A1 ; Khaheshi I1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Experimental Medicsearch Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Biomedica Published:2020


Abstract

The COVID-19 epidemic initially started in Wuhan, China in December 2019 due to SARSCoV-2. SARS-CoV-2 is genetically similar to the bat beta-coronavirus genus, but the novel specie of this genus can infect humans. The most common clinical features of COVID-19 are fever, cough, myalgia, fatigue, expectoration, and dyspnea. The primary reported mortality rate was about 2-3% in China; however, it reached up to 10% among patients with underlying cardiovascular diseases. The primary epidemiological investigations showed a high prevalence of underlying cardiovascular diseases in more than 40% of infected patients. A high prevalence of hypertension, ischemic heart disease, and diabetes were reported among deceased patients in Italy. Previous experiments in different pandemic situations showed that the cardiovascular system has been affected in many ways. Previous studies on SARS-CoV and MERS-CoV reported that cardiovascular co-morbidities had a direct correlation with the risk of infection, the severity of disease, and the mortality rate. Therefore, brief and available protocols for controlling the negative effects of this novel respiratory infection on the cardiovascular system, especially in a high-risk populations with underlying cardiovascular conditions, is one of the most serious concerns among healthcare providers. Herein, we aimed to review the available data on the cardiac manifestation of COVID-19. Besides, we described useful maps for the better treatment of COVID-19 infection in patients with underlying cardiovascular conditions, as a highrisk group of patients. (www.actabiomedica.it). © 2020, Mattioli 1885. All rights reserved.
Related Docs
View other Related Docs
1. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
2. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
3. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
4. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (Covid-19), Journal of Cardiovascular Pharmacology (2020)
5. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
6. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)
7. Covid-19 and Cardiovascular Diseases, Advances in Experimental Medicine and Biology (2021)
8. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (9)
Hossein Khalili (8)
Other Related Docs
9. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
10. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
11. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
12. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
13. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
14. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
15. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
16. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
17. Pathophysiology of Covid-19 Infection: What Is the Novel Coronavirus (Sars-Cov-2) Doing to Body? a Comprehensive Systematic Review, Reviews and Research in Medical Microbiology (2021)
18. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
19. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
20. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
21. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
22. Nanomedicine “New Food for an Old Mouth”: Novel Approaches for the Treatment of Covid-19, Drug Delivery Letters (2023)
23. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
24. Pharmacotherapy Considerations in Ckd Patients With Covid-19, a Narrative Review, Iranian Journal of Kidney Diseases (2020)
25. Safety and Effectiveness of Favipiravir for Novel Coronavirus (Covid-19): A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
26. Comparison of the Eight Different Treatment Regimens for the Hospitalized Patients With Covid-19: A Retrospective Cohort Study, Journal of Cellular and Molecular Anesthesia (2021)
27. Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients, Future Microbiology (2020)
28. Real Clinical Practice and Therapeutic Management Following Covid-19 Crisis in Two Hospitals in Iran: A Statistical and Conceptual View, Tanaffos (2020)
29. Pharmacotherapeutic Considerations in Solid Organ Transplant Patients With Covid-19, Expert Opinion on Pharmacotherapy (2020)
30. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
31. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
32. Cardiovascular Implications of the Covid-19: Management of Complications and Drug Safety Concerns, Journal of Research in Medical Sciences (2022)
33. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
34. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
35. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
36. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
37. Targeted Delivery of Crispr/Cas13 As a Promising Therapeutic Approach to Treat Sars-Cov-2, Current Pharmaceutical Biotechnology (2021)
38. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
39. The Prognostic Value of Comorbidity for the Severity of Covid-19: A Systematic Review and Meta-Analysis Study, PLoS ONE (2021)
40. A Randomized Clinical Trial of the Efficacy and Safety of Interferon Β-1A in Treatment of Severe Covid-19, Antimicrobial Agents and Chemotherapy (2020)
41. Comparing Outcomes of Hospitalized Patients With Moderate and Severe Covid-19 Following Treatment With Hydroxychloroquine Plus Atazanavir/Ritonavir, DARU# Journal of Pharmaceutical Sciences (2020)
42. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
43. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
44. The Impact of Sofosbuvir/Daclatasvir or Ribavirin in Patients With Severe Covid-19, Journal of Antimicrobial Chemotherapy (2020)
45. Selective Serotonin Reuptake Inhibitors: New Hope in the Fight Against Covid-19, Frontiers in Pharmacology (2022)
46. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
47. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
48. Do Interferons Play a Role in Covid-19?, International Journal of Clinical Practice (2021)
49. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
50. Nanobionics: From Plant Empowering to the Infectious Disease Treatment, Journal of Controlled Release (2022)